Please ensure Javascript is enabled for purposes of website accessibility

Why Pactiv Evergreen Stock Ended in the Red Today

By Rich Smith - Feb 25, 2021 at 4:24PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Did Pactiv miss earnings? Because Bank of America said it missed earnings.

What happened

Shares of fresh food and beverage distributor Pactiv Evergreen (PTVE 3.97%) crashed Thursday, closing the trading session down by 9.8% after the company reported earnings for the fourth quarter and full year.

Pactiv earned $0.10 per share in Q4 2020, versus a $1.03 per share loss in Q4 2019. That sounds pretty good, but according to Bank of America, it was an "earnings miss." BofA analyst George Staphos downgraded the stock to neutral Thursday morning, reported financial news website The Fly -- and so some investors are selling.

White arrow declining sharply atop a stock tickertape display bathed in red

Image source: Getty Images.

So what

That downgrade aside, though, how bad was the quarter, really?  

Sales declined 10% year over year to $1.2 billion -- not great, but probably not surprising, considering that the economy's still stuck in a recession and fighting a pandemic. And viewed in that context, the fact that Pactiv ended the year with no worse than an $0.08 loss from continuing operations is actually pretty impressive -- as is the fact that it earned $0.10 per share in 2020's final quarter.

CEO John McGrath pronounced himself "pleased that our fourth quarter 2020 operating performance ended near the prior year and where we were expecting despite ongoing headwinds from the impacts of COVID-19," and I have to agree.

Now what

That being said, the outlook for next year still doesn't really impress. Pactiv warns of "continued softened demand in its Foodservice and Beverage Merchandising segments" due to COVID-19. The company's also just now recovering from winter storm damage to its southern facilities, and it warns that "the financial impact of this event is still being assessed," as are the effects of the winter weather on its operations elsewhere in the country.

The best Pactiv can say right now is that it "expects a strong second half of 2021 as the vaccine roll-out is forecasted to reach critical mass." That implies perhaps six long months of bad news before any good news can arrive.

Judging from Thursday's share price action, it seems not all investors are interested in waiting that long.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Pactiv Evergreen Inc. Stock Quote
Pactiv Evergreen Inc.
PTVE
$10.73 (3.97%) $0.41

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
338%
 
S&P 500 Returns
119%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.